Jane Street Group, LLC Zymeworks Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$27.35 - $37.28 $84,785 - $115,568
3,100 Added 72.09%
7,400 $215,000
Q4 2020

Feb 17, 2021
SELL
$39.12 - $54.99 $152,568 - $214,461
-3,900 Reduced 47.56%
4,300 $203,000
Q2 2020

Aug 17, 2020
BUY
$33.67 - $40.0 $276,094 - $328,000
8,200 New
8,200 $296,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $906M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email